Blood & Cancer
A weekly interview-style podcast hosted by Dr. David Henry that takes developments in hematology-oncology and asks, "Now what?"
@davidhenrymd. Dr. Henry reported being on the advisory board for Amgen, AMAG Pharmaceuticals, and Pharmacosmos. He reported institutional funding from the National Institutes of Health and FibroGen.@ilanayurkiewicz. Dr. Yurkiewicz has no relevant conflicts of interest.